Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer AK Nurgalieva, VE Popov, VS Skripova, LF Bulatova, DV Savenkova, ... Biochemistry and Biophysics Reports 28, 101104, 2021 | 8 | 2021 |
Physcion enhances sensitivity of pancreatic adenocarcinoma and lung carcinoma cell lines to cisplatin DV Savenkova, КV Havrysh, VS Skripova, NE Ionova, AK Nurgalieva, ... BioNanoScience 10, 549-553, 2020 | 4 | 2020 |
53P Expression of sodium-dependent phosphate transporter NaPi2b is downregulated in malignant ovarian tumors after neoadjuvant chemotherapy AK Nurgalieva, S Safina, E Shakirova, V Filonenko, V Skripova, ... Annals of Oncology 32, S1361-S1362, 2021 | 2 | 2021 |
Toward a Topology-Based Therapeutic Design of Membrane Proteins: Validation of NaPi2b Topology in Live Ovarian Cancer Cells L Bulatova, D Savenkova, A Nurgalieva, D Reshetnikova, A Timonina, ... Frontiers in Molecular Biosciences 9, 895911, 2022 | 1 | 2022 |
26P Structurally constrained tumor-specific epitope within the largest extracellular domain of sodium-dependent phosphate transporter NaPi2b LF Bulatova, V Skripova, A Nurgalieva, D Reshetnikova, DV Savenkova, ... Annals of Oncology 32, S368-S369, 2021 | 1 | 2021 |
65P Transmembrane distribution of phosphatidylethanolamine in plasma membrane of ovarian cancer cells under conditions mimicking tumor microenvironment D Savenkova, LF Bulatova, I Makarenko, D Nedorezova, I Levashov, ... ESMO Open 8 (1), 2023 | | 2023 |
Recognition of cysteine mutant forms of the sodiumdependent phosphate transporter NaPi2b by monoclonal antibodies in ovarian cancer cells OVCAR-8 L Bulatova, D Savenkova, D Reshetnikova, A Timonina, A Nurgalieva, ... CELL DEATH DISCOVERY 8, 5-6, 2022 | | 2022 |
81P Effect of disulfide bonds and N-glycosylation on the recognition of the NaPi2b transporter by monoclonal antibodies D Reshetnikova, LF Bulatova, V Skripova, D Savenkova, AK Nurgalieva, ... Annals of Oncology 33, S1408, 2022 | | 2022 |
Topology of sodium-dependent phosphate transporter NaPi2b in live ovarian cancer cells LB Minigulova, D Savenkova, V Skripova, A Nurgalieva, D Reshetnikova, ... EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 52, 2022 | | 2022 |
Lipid-assisted folding defines recognition of conformationally exposed cancer specific napi2b epitope by monoclonal antibodies in ovarian cancer cells D Savenkova, LB Minigulova, A Kozlova, R Vlasenkova, N Akberova, ... EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 52, 2022 | | 2022 |
Interplay of Lipid-Assisted and Oxidative Folding of Largest Extracellular Domain Defines Transport Function of Secondary Transporter NaPi2b in Cancer Cells DV Savenkova, DD Reshetnikova, LF Bulatova, AS Kozlova, NI Akberova, ... Липиды 2021, 169-171, 2021 | | 2021 |
The combined action of cisplatin and Physcion increases the ROS level in the lung and pancreas cancer cells DV Savenkova, K Havrysh, VS Skripova, AK Nurgalieva, LF Minigulova, ... HUMAN GENE THERAPY 30 (11), A62-A62, 2019 | | 2019 |
Investigation of the combined action of cisplatin and 6-phosphogluconate dehydrogenase inhibitor on pancreatic and lung cancer cell lines DV Savenkova, LF Minigulova, KV Havrysh, VS Skripova, RG Kiyamova Annals of Oncology 29, vi5, 2018 | | 2018 |
The effect of small molecule compounds Physcion and PFI-3 on the sensitivity of the tumor cell lines SCC61 and AcPC-1 to cisplatin D Savenkova, L Minigulova, K Havrysh, V Skripova, I Serebriiskii, ... EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 48, 220-221, 2018 | | 2018 |
Physcion Enhances Sensitivity of Pancreatic Adenocarcinoma and Lung Carcinoma Cell Lines to Cisplatin LF Minigulova, MV Bogdanov, NE Ionova, VS Skripova, DV Savenkova, ... | | |
Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer SZ Safina, RA Vlasenkova, EZ Shakirova, MV Bogdanov, VS Skripova, ... | | |